课题基金 / 基金详情

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCH

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCH
DFCI-BIDMC-CH 艾滋病研究中心
批准号:
6652095
负责人:
JOSEPH G SODROSKI
金额:
$161.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-15 至 2007-07-31

项目摘要

项目成果

JOSEPH G SODROSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
OVERALL DESCRIPTION (adapted from the application): This application proposes the establishment of the Dana-Farber Cancer Institute Beth Israel Deaconess Medical Center, and Children's Hospital (DFCI-BIDMC-CH) Center for AIDS Research (DFCI-BIDMC-CH CFAR). The DFCI-BIDMC-CH CFAR encompasses clinical and basic science research conducted at the Dana-Farber Cancer Institute Beth Israel Deaconess Medical Center, and Children's Hospital. The DFCI-BIDMC-CH CFAR is the product of the longstanding commitment of these institutions to AIDS research and patient care, and builds upon an existing Center for AIDS Research at the Dana-Farber Institute. The CFAR award would support the continuation or establishment of six scientific Core Facilities. The Administrative Core provides administrative support to: 1) the CFAR leadership, including the Executive Committee and five advisory committees; 2) the Development and Clinical Cores; 3) the Core Facilities; and 4) the CFAR membership. The Development Core will be utilized to enhance the CFAR research program by providing support for new investigators to develop AIDS-related research activities and for pilot projects to exploit innovative ideas and technology for AIDS research. The Biohazard Containment Core provides a Biosaftey Level 3 facility for the propagation and purification of human or simian immunodeficiency viruses for the interdisciplinary team of CFAR investigators. The purpose of the Animal Biohazaard Containment (ABC) Core Facility is to provide support for AIDS-related mouse work that requires biosafety levels 2 or 3 containment. The Molecular Biology Core Facility provides oligonucleotides and conjugated or unconjugated peptides on a charge-back basis. The cell culture facility is designed to provide large amounts of monoclonal antibodies and purified proteins to researchers for the use in AIDS related research. The major emphasis of the Clinical Core is to develop clinical AIDS research in the CFAR member institutions and the surrounding community. The Biostatistics Core supports consultation and collaboration on quantitative methods to investigators throughout the CFAR.
期刊论文(106)
专著(0)
科研奖励(0)
会议论文
Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity.
工程化 T 细胞受体四聚体以高亲和力结合 MHC-肽复合物。
DOI: 10.1038/nbt1024
发表时间: 2004
期刊: Nature biotechnology
影响因子: 46.9
作者: [Subbramanian,RamuA, Moriya,Chikaya, Martin,KristiL, Peyerl,FredW, Hasegawa,Atsuhiko, Naoi,Akira, Chhay,Heng, Autissier,Patrick, Gorgone,DarciA, Lifton,MichelleA, Kuus-Reichel,Kristine, Schmitz,JörnE, Letvin,NormanL, Kuroda,MarceloJ]
通讯作者: Kuroda,MarceloJ
Cyclic AMP-mediated growth arrest is associated with increased expression of human T cell leukemia virus type I structural and transforming genes.
环 AMP 介导的生长停滞与人 T 细胞白血病病毒 I 型结构和转化基因的表达增加有关。
DOI: 10.1089/aid.1996.12.527
发表时间: 1996
期刊: AIDS research and human retroviruses.
影响因子: --
作者: [Poteat,HT, Ramstedt,U, Yoon,S, Dardik,M, Terwilliger,E, Sodroski,JG]
通讯作者: Sodroski,JG
DOI: 10.1084/jem.20020468
发表时间: 2002-08-19
期刊: The Journal of experimental medicine
影响因子: --
作者: [LaBonte JA, Babcock GJ, Patel T, Sodroski J]
通讯作者: Sodroski J
Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.
人类免疫缺陷病毒1型gp120包膜糖蛋白与gp41跨膜糖蛋白的相互作用分析。
DOI: 10.1128/jvi.71.12.9722-9731.1997
发表时间: 1997
期刊: Journal of virology
影响因子: 5.4
作者: [Wyatt,R, Desjardin,E, Olshevsky,U, Nixon,C, Binley,J, Olshevsky,V, Sodroski,J]
通讯作者: Sodroski,J
23
    Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein
    • 批准号:
      10094191
    • 项目类别:
    • 资助金额:
      $75.08万
    • 财政年份:
      2019
    • 负责人:
      JOSEPH G SODROSKI
    • 依托单位:
    Reducing viral reservoirs by opening HIV-1 Env to antibody attack
    • 批准号:
      9258013
    • 项目类别:
    • 资助金额:
      $21.62万
    • 财政年份:
      2017
    • 负责人:
      JOSEPH G SODROSKI
    • 依托单位:
    Reducing viral reservoirs by opening HIV-1 Env to antibody attack
    • 批准号:
      9889022
    • 项目类别:
    • 资助金额:
      $50.79万
    • 财政年份:
      2017
    • 负责人:
      JOSEPH G SODROSKI
    • 依托单位:
    Conformational Landscape of the HIV-1 Envelope Glycoproteins
    • 批准号:
      10394418
    • 项目类别:
    • 资助金额:
      $63.77万
    • 财政年份:
      2016
    • 负责人:
      JOSEPH G SODROSKI
    • 依托单位:
    海外基金